Small study tackles nasty side effect of lung drug

NCT ID NCT06200714

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 18 people in Spain with idiopathic pulmonary fibrosis (IPF) or other progressive lung scarring who were taking nintedanib (OFEV) and had developed diarrhea. The goal was to see if the diarrhea could be controlled after 12 weeks while staying on the full dose. Researchers tracked how many patients had fewer than 3 loose stools per day. It is an observational study, meaning no new treatment was tested—just real-world data collection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
nintedanib (OFEV)
What this could lead to
If successful, this could help doctors manage a common side effect of nintedanib, allowing patients to stay on their lung fibrosis treatment with less discomfort.
What could go wrong
This is a very small observational study (18 people) with no control group, so results may not apply to everyone. It only looks at diarrhea control, not whether the drug works for the lung disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIARRHOEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Clínic i Provincial de Barcelona

    Barcelona, 08036, Spain

  • Hospital Clínico San Carlos

    Madrid, 28040, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, 46010, Spain

  • Hospital Universitari Germans Trias i Pujol

    Barcelona, 08916, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014, Spain

  • Hospital Universitario de Cruces

    Bizkaia, 48903, Spain

  • Hospital de La Princesa

    Madrid, 28006, Spain

  • Hospital Álvaro Cunqueiro

    Pontevedra, 36312, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.